Determination of Essential Components of Compound of Loratadine, Paracetamol and Pseudoephedrine by Liquid Chromatography-Tandem Spectrometry and Its Pharmacokinetics

LI Xuening,XU Jianan,CHEN Weili,XU Hongrong,YU Chen,LIU Gangyi,JIA Jingying

DOI: https://doi.org/10.3969/j.issn.1007-4406.2008.01.003

2008-01-01

Abstract:AIM To evaluate the safety and pharmacokinetic parameters of a compound of loratadine,paracetamol and pseudoephedrine in Chinese healthy volunteers.METHODS Eight Chinese healthy volunteers were given the com- pound of single and multiple doses.The concentration of loratadine,paracetamol and pseudoephedrine in blood plasma was measured by a validated LE-MS/MS method and was assessed with non-compartment model to obtain the pharmacoki- netic parameters.RESULTS The pharmacokinetic parameters of loratadine,paracetarnol and pseudoephedrine for a sin- gle dose were as follows:AUC_(0→t):(18.04±13.81),(26 455.42±5 245.72),(3 703.16±487.26)μg·h·L~(-1);ρ_(max): (6.81±4.98),(3 918.75±816.17) and (423.63±49.55)μg·L~(-1);t_(max):(0.91±0.30),(4.13±1.13) and (5.25±0.89)h;t_(1/2):(3.71±1.72),(5.34±2.02) and (11.81±5.08) h.The pharmacokinetic parameters of lorata- dine,paracetamol and pseudoephedrine for multiple doses were as follows:AUC~(ss) :(63.26±39.58),(49 226.51±11 103.51)and (I1 046.73±12 642.36)μg·h·L~(-1);ρ_(max):(6.36±3.31),(5 733.75±1 099.06)and (576.38±136.48)μg·L~(-1);ρ_(min):(1.08±0.74),(1 890.63±350.06) and (247.88±71.35)μg·L~(-1);t_(max):(1.13±0.55), (2.31±0.88) and (3.38±1.06)h;ρ_(av):(3.72±2.00),(3 812.19±576.16) and (412.13±94.01)μg·L~(-1);DF: (143.02±26.11),(99.54±21.74) and (80.07±18.09) %.CONCLUSION The results show that there are no sig- nificant differences among the main pharmacokinetic parameters of loratadine,paracetamol and pseudoephedrine after ad- ministrating single and multiple oral dose of the compound in healthy volunteers.There is no accumulation after multiple doses of the compound.There are no any adverse events observed during the whole study.